您好,欢迎访问浙江省农业科学院 机构知识库!

Synbiotic Effects of Lacticaseibacillus paracasei K56 and Prebiotics on the Intestinal Microecology of Children with Obesity

文献类型: 外文期刊

作者: Zhang, Pengwei 1 ; Dong, Xianhui 1 ; Zeng, Yijun 2 ; Chen, Junkui 3 ; Yang, Sijia 2 ; Yu, Peipei 2 ; Ye, Chunhong 2 ; Hung, Wei-Lian 4 ; Jiang, Qiuyue 4 ; Zhao, Wen 4 ; Zeng, Zhaozhong 4 ; Li, Jinjun 6 ; Li, Li 1 ;

作者机构: 1.Hangzhou Normal Univ, Affiliated Hosp Hangzhou Normal Univ, Hangzhou 310015, Peoples R China

2.Hangzhou Normal Univ, Hangzhou 310015, Peoples R China

3.Hangzhou Hailu Med Technol Co Ltd, Hangzhou 310015, Peoples R China

4.Inner Mongolia Yili Ind Grp Co Ltd, Hohhot, Peoples R China

5.Inner Mongolia Dairy Technol Res Inst Co Ltd, Hohhot 010000, Peoples R China

6.Zhejiang Acad Agr Sci, Inst Food Sci, Hangzhou 30021, Peoples R China

关键词: Lacticaseibacillus paracasei K56; Galactooligosaccharide; Xylooligosaccharide; Polyglucose; Synbiotics; Childhood obesity

期刊名称:PROBIOTICS AND ANTIMICROBIAL PROTEINS ( 影响因子:4.4; 五年影响因子:5.0 )

ISSN: 1867-1306

年卷期: 2024 年

页码:

收录情况: SCI

摘要: Lacticaseibacillus paracasei K56 (L. paracasei K56) is a probiotic with weight-loss effects. However, symbiosis research on the combined effects of Lacticaseibacillus paracasei K56 and prebiotics is lacking. Therefore, the aim of this study was to investigate the effects of L. paracasei K56, xylooligosaccharide (XOS), galactooligosaccharide (GOS), polyglucose (PG), and their synbiotic combinations (XOS + K56, GOS + K56, and PG + K56) on metabolism and gut composition in children with obesity, using an in vitro fermentation model. Fecal samples were collected from 14 children with obesity for in vitro fermentation, and the effects of the various treatments in gas production and short chain fatty acid synthesis (SCFAs) were assessed. Treatment with probiotics, prebiotics, and synbiotics regulated gut microbiota and metabolites in children with obesity. GOS and XOS had higher degradation rates than PG + K56 synbiotics in the gut microbiota of children with obesity. Moreover, treatment with XOS, GOS, and their synbiotic combinations, (XOS + K56) and (GOS + K56), significantly reduced the production of gas, propionic acid, and butyric acid compared with PG + K56 treatment. Treatments with GOS + K56 and XOS + K56 altered the composition of the gut microbiota, improved the abundance of Bifidobacteria and Lactobacilli, and reduced the abundance of Escherichia/Shigella. Overall, this study provides a theoretical foundation for the use of K56-based synbiotics.

  • 相关文献
作者其他论文 更多>>